s6y Raphael Pharmaceutical Inc. POS AM

Raphael Pharmaceutical Inc. POS AM, filed Jun 1, 2023: CONSENT OF BRIGHTMAN ALMAGOR ZOHAR & CO

Exhibit 23.3

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the use, in this Registration Statement No. 333-260766 on Form S-1, of our report dated March 30, 2022, relating to the financial statements of Raphael Pharmaceutical Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement. 

 

/s/ Brightman Almagor Zohar & Co.

Certified Public Accountants

A Firm in the Deloitte Global Network

 

Tel Aviv, Israel

June 1, 2023